{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:53:08Z","timestamp":1787003588033,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Research Foundation of Korea (NRF) grant funded by the Korea government","award":["RS-2024-00392315"],"award-info":[{"award-number":["RS-2024-00392315"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-00452-1","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T09:07:04Z","timestamp":1746608824000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparative analysis of oncologic outcomes in surgically treated patients with renal cell carcinoma and renal vein thrombosis by pathologic subtypes"],"prefix":"10.1038","volume":"15","author":[{"given":"Dongrul","family":"Shin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bumjin","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryn","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalsan","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Gab","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Hyuk","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanjong","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bumsik","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Wook","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jang Hee","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungyo","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"key":"452_CR1","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.clgc.2017.03.004","volume":"15","author":"G De Velasco","year":"2017","unstructured":"De Velasco, G. et al. Comprehensive analysis of survival outcomes in non-clear cell renal cell carcinoma patients treated in clinical trials. Clin. Genitourin. Cancer 15, 652-660.e1 (2017).","journal-title":"Clin. Genitourin. Cancer"},{"key":"452_CR2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00345-020-03187-y","volume":"39","author":"G Rosiello","year":"2021","unstructured":"Rosiello, G. et al. Comparison of survival outcomes in patients with metastatic papillary vs. clear-cell renal cell carcinoma: A propensity-score analysis. World J. Urol. 39, 461\u2013472 (2021).","journal-title":"World J. Urol."},{"key":"452_CR3","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.eururo.2014.05.010","volume":"67","author":"FE Vera-Badillo","year":"2015","unstructured":"Vera-Badillo, F. E. et al. Systemic therapy for non-clear cell renal cell carcinomas: A systematic review and meta-analysis. Eur. Urol. 67, 740\u2013749 (2015).","journal-title":"Eur. Urol."},{"key":"452_CR4","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.3390\/cancers13153807","volume":"13","author":"P Sepe","year":"2021","unstructured":"Sepe, P. et al. Characteristics and treatment challenges of non-clear cell renal cell carcinoma. Cancers 13, 3807 (2021).","journal-title":"Cancers"},{"key":"452_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.euros.2023.04.015","volume":"52","author":"SM Monda","year":"2023","unstructured":"Monda, S. M. et al. The metastatic risk of renal cell carcinoma by primary tumor size and subtype. Eur. Urol. Open Sci. 52, 137\u2013144 (2023).","journal-title":"Eur. Urol. Open Sci."},{"key":"452_CR6","volume":"23","author":"JJ Adashek","year":"2020","unstructured":"Adashek, J. J., Genovese, G., Tannir, N. M. & Msaouel, P. Recent advancements in the treatment of metastatic clear cell renal cell carcinoma: A review of the evidence using second-generation p-values. Cancer Treat. Res. Commun. 23, 100166 (2020).","journal-title":"Cancer Treat. Res. Commun."},{"key":"452_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.euros.2022.07.001","volume":"43","author":"MJ Rabinowitz","year":"2022","unstructured":"Rabinowitz, M. J. et al. Characterizing tumor thrombus arising from non-clear cell renal cell carcinoma. Eur. Urol. Open Sci. 43, 28\u201334 (2022).","journal-title":"Eur. Urol. Open Sci."},{"key":"452_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1471-2490-13-47","volume":"13","author":"S Hatakeyama","year":"2013","unstructured":"Hatakeyama, S. et al. Prognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center. BMC Urol 13, 47 (2013).","journal-title":"BMC Urol"},{"key":"452_CR9","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.eururo.2022.08.019","volume":"82","author":"L Bukavina","year":"2022","unstructured":"Bukavina, L. et al. Epidemiology of renal cell carcinoma: 2022 Update. Eur. Urol. 82, 529\u2013542 (2022).","journal-title":"Eur. Urol."},{"key":"452_CR10","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12885-019-5359-0","volume":"19","author":"C Cao","year":"2019","unstructured":"Cao, C. et al. Long-term survival and prognostic factors for locally advanced renal cell carcinoma with renal vein tumor thrombus. BMC Cancer 19, 144 (2019).","journal-title":"BMC Cancer"},{"key":"452_CR11","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1186\/s12885-021-08508-x","volume":"21","author":"Z Chen","year":"2021","unstructured":"Chen, Z. et al. Outcomes of renal cell carcinoma with associated venous tumor thrombus: Experience from a large cohort and short time span in a single center. BMC Cancer 21, 766 (2021).","journal-title":"BMC Cancer"},{"key":"452_CR12","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.urology.2013.02.034","volume":"82","author":"D Kaushik","year":"2013","unstructured":"Kaushik, D. et al. The impact of histology on clinicopathologic outcomes for patients with renal cell carcinoma and venous tumor thrombus: A matched cohort analysis. Urology 82, 136\u2013141 (2013).","journal-title":"Urology"},{"key":"452_CR13","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","volume":"82","author":"H Moch","year":"2022","unstructured":"Moch, H. et al. The 2022 World Health Organization classification of tumours of the urinary system and male genital organs\u2014Part A: Renal, penile, and testicular tumours. Eur. Urol. 82, 458\u2013468 (2022).","journal-title":"Eur. Urol."},{"key":"452_CR14","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.eururo.2017.12.018","volume":"73","author":"GP Paner","year":"2018","unstructured":"Paner, G. P. et al. Updates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancers. Eur. Urol. 73, 560\u2013569 (2018).","journal-title":"Eur. Urol."},{"key":"452_CR15","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/j.1464-410X.1987.tb04832.x","volume":"59","author":"RJ Neves","year":"1987","unstructured":"Neves, R. J. & Zincke, H. Surgical treatment of renal cancer with vena cava extension. Br. J. Urol. 59, 390\u2013395 (1987).","journal-title":"Br. J. Urol."},{"key":"452_CR16","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S1470-2045(23)00276-0","volume":"24","author":"L Albiges","year":"2023","unstructured":"Albiges, L. et al. Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): A single-arm, multicentre, phase 2 trial. Lancet Oncol. 24, 881\u2013891 (2023).","journal-title":"Lancet Oncol."},{"key":"452_CR17","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1200\/JCO.20.02365","volume":"39","author":"DF McDermott","year":"2021","unstructured":"McDermott, D. F. et al. Open-label, single-arm, phase II study of pembrolizumab monotherapy as first-line therapy in patients with advanced non-clear cell renal cell carcinoma. JCO 39, 1029\u20131039 (2021).","journal-title":"JCO"},{"key":"452_CR18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2147\/RRU.S154932","volume":"10","author":"D Sirohi","year":"2018","unstructured":"Sirohi, D., Smith, S. C., Agarwal, N. & Maughan, B. L. Unclassified renal cell carcinoma: Diagnostic difficulties and treatment modalities. RRU 10, 205\u2013217 (2018).","journal-title":"RRU"},{"key":"452_CR19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.clgc.2020.11.005","volume":"19","author":"P Zoumpourlis","year":"2021","unstructured":"Zoumpourlis, P., Genovese, G., Tannir, N. M. & Msaouel, P. Systemic therapies for the management of non-clear cell renal cell carcinoma: What works, what doesn\u2019t, and what the future holds. Clin. Genitourin. Cancer 19, 103\u2013116 (2021).","journal-title":"Clin. Genitourin. Cancer"},{"key":"452_CR20","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/iju.14523","volume":"28","author":"H Ishihara","year":"2021","unstructured":"Ishihara, H. et al. Effect of improved systemic therapy on patient survival in metastatic non-clear-cell renal cell carcinoma. Int. J. Urol. 28, 605\u2013607 (2021).","journal-title":"Int. J. Urol."},{"key":"452_CR21","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/ijc.34756","volume":"154","author":"NR Wilson","year":"2024","unstructured":"Wilson, N. R., Acikgoz, Y. & Hasanov, E. Advances in non-clear cell renal cell carcinoma management: From heterogeneous biology to treatment options. Int. J. Cancer 154, 947\u2013961 (2024).","journal-title":"Int. J. Cancer"},{"key":"452_CR22","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1056\/NEJMoa2312695","volume":"390","author":"K Choueiri Toni","year":"2024","unstructured":"Choueiri Toni, K. et al. Overall survival with adjuvant pembrolizumab in renal-cell carcinoma. New Engl. J. Med. 390, 1359\u20131371 (2024).","journal-title":"New Engl. J. Med."},{"key":"452_CR23","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1056\/NEJMoa2106391","volume":"385","author":"K Choueiri Toni","year":"2021","unstructured":"Choueiri Toni, K. et al. Adjuvant pembrolizumab after nephrectomy in renal-cell carcinoma. New Engl. J. Med. 385, 683\u2013694 (2021).","journal-title":"New Engl. J. Med."},{"key":"452_CR24","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1016\/j.clgc.2022.09.009","volume":"21","author":"F Izarn","year":"2023","unstructured":"Izarn, F. et al. Real world data of diagnosis, survival, and treatment outcomes in patients with metastatic non clear cell renal cell carcinoma. Clin. Genitourin. Cancer 21, e35\u2013e43 (2023).","journal-title":"Clin. Genitourin. Cancer"},{"key":"452_CR25","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.3390\/cancers11081110","volume":"11","author":"A Cali\u00f2","year":"2019","unstructured":"Cali\u00f2, A., Segala, D., Munari, E., Brunelli, M. & Martignoni, G. MiT family translocation renal cell carcinoma: From the early descriptions to the current knowledge. Cancers 11, 1110 (2019).","journal-title":"Cancers"},{"key":"452_CR26","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00428-022-03380-x","volume":"481","author":"A Cali\u00f2","year":"2022","unstructured":"Cali\u00f2, A. et al. TFE3 and TFEB-rearranged renal cell carcinomas: An immunohistochemical panel to differentiate from common renal cell neoplasms. Virchows Arch. 481, 877\u2013891 (2022).","journal-title":"Virchows Arch."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00452-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00452-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00452-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T08:39:57Z","timestamp":1764923997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00452-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["452"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-00452-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,7]]},"assertion":[{"value":"10 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this Article was revised: The Acknowledgements section was incomplete. The correct information now accompanies the original Article.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15946"}}